Public Documents

Public Documents - All Categories

Side Effects Blog: FDA May Require New Onglyza Drug Label For Warning About Heart Failure SUMMARY: In April 2015 the results of the "Saxagliptin Assessment of Vascular Outcomes Recorded in Patients with Diabetes Mellitus (SAVOR)" trial for for AstraZeneca's relatively new diabetes drugs Onglyza (saxagliptin) and Kombiglyze XR (saxagliptin and metformin HCI extended-release) were discussed recently by an FDA Advisory Committee panel of medical experts.
Posted by Tom Lamb on 7.27.15 in Personal Injury.
Side Effects Blog: Federal Court Zofran MDL Motion; Generic Cases Filed In State Courts SUMMARY: According a motion filed by GlaxoSmithKline (Glaxo) with the U.S. Judicial Panel on Multidistrict Litigation (JPML), as of early July 2015 there were 12 Zofran lawsuits filed in 10 different federal court jurisdictions.
Posted by Tom Lamb on 7.21.15 in Personal Injury.
Hellen works with civil litigation solicitors burnley can help you receive professional legal services. We have years of experience in the fields of whiplash injury compensation, crime, immigration and Personal Injury.
Posted by hellen geek on 7.16.15 in Articles.
Side Effects Blog: Invokana Lawsuits Filed While FDA Investigates Side Effects Reports SUMMARY: Invokana -- first available in 2014 -- is part of a new class of diabetes medications called Sodium-Glucose Co-Transporter-2 (SGLT2) Inhibitors, which also these drugs:
Posted by Tom Lamb on 7.6.15 in Personal Injury.
Side Effects Blog: Farxiga / Jardiance / Invokana: Ketoacidosis and Kidney Failure SUMMARY: On June 22, 2015 Health Canada sent a MedEffect email alert about its "Information Update - Forxiga, Invokana: Health Canada begins safety review of diabetes drugs known as SGLT2 inhibitors and risk of ketoacidosis".
Posted by Tom Lamb on 6.29.15 in Personal Injury.
The Certificate of habitability is an important document you should take into consideration when deciding to buy a property in Italy.
Posted by Giandomenico De Tullio on 6.29.15 in Real Estate. (IT)
According To Bayer, In April 2015 There Were 400 Fewer YAZ / Yasmin Lawsuits Pending, 100 More Settlements, And 500 Cases Just Seem To Vanish From Their Radar Now About Six Years Out From When This Beyaz / Safyral / YAZ / Yasmin / Gianvi / Ocella Drug Injury Litigation Started, Bayer Continues Its Slow-Going Pace
Posted by Tom Lamb on 6.25.15 in Personal Injury - Personal Injury.
Drug Injury Watch: Fosamax - Femur Fracture Lawsuits Update: California Verdict For Merck In April 2015 With Two More California Trials Scheduled For July 2015 And October 2015 Federal Court Fosamax MDL Reassigned From Judge Pisano To Judge Wolfson While We Wait For Appellate Court To Rule On Appeals From Glynn And Gaynor Case Rulings
Posted by Tom Lamb on 6.18.15 in Personal Injury.
Drug Injury Watch: Invokana / Farxiga / Jardiance: New Medical Study Finds A History Of Diabetic Ketoacidosis Events Is Associated With Increased Risk of Death This Ketoacidosis Side Effect For These New Diabetes Medicines Was The Subject Of A May 2015 FDA Drug Safety Warning Which Was, Perhaps, Not Strong Enough About Dangers
Posted by Tom Lamb on 6.12.15 in Personal Injury.
Drug Injury Watch: Multiple Myeloma Drug Pomalyst Associated With Side Effects Risks Of Cardiac Failure, Interstitial Lung Disease, And Hepatotoxicity In May 2015 The Medicines and Healthcare Products Regulatory Agency In UK Issued A Drug Safety Update; Will There Be Similar FDA Action?
Posted by Tom Lamb on 6.5.15 in Personal Injury.